Copyright
©The Author(s) 2024.
World J Virol. Mar 25, 2024; 13(1): 91457
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.91457
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.91457
Table 3 Baseline laboratory parameters and hospital course
Parameter of interest | Frequency (%) |
Hematocrit, median | 42.60 (IQR 15.15) |
Total leucocyte count (per µL), median | 5800 (IQR 5800) |
Platelet count (per µL), median | 25500 (IQR 28250) |
AST (U/L), median | 4625 (IQR 11902.5) |
ALT (U/L), median | 3100 (IQR 2607) |
AST/ALT ratio, median | 2.45 (IQR 1.75) |
Alkaline phosphatase (IU/L), median | 191 (IQR 117) |
Total bilirubin (mg/dL), median | 5.5 (IQR 5.63) |
Direct bilirubin (mg/dL), median | 2.55 (IQR 2.75) |
INR, median | 2.13 (IQR 1.79) |
Albumin (g/L), median | 2.85 (IQR 0.48) |
Creatinine (mg/dL), median | 1.63 (IQR 2.12) |
MELD score, median | 27.5 (IQR 5) |
Days of ICU stay, median | 6 (IQR 2) |
Specific therapies | |
N-acetyl cysteine | 6 (31.6) |
Types of organ support | |
Vasopressors | 8 (42.1) |
Renal replacement therapy | 6 (31.6) |
Ventilation | 6 (31.6) |
MARS | 1 (5.3) |
Organ failure | 14 (73.7) |
Neurological | 10 (52.6) |
Cardiac | 8 (42.1) |
Renal | 7 (36.8) |
Respiratory | |
Complications | |
Hepatic encephalopathy | 13 (68.4) |
Bleedings | 3 (15.8) |
DVT | 1 (5.3) |
Liver transplantation | 2 (10.5) |
Death | 1 (5.3) |
- Citation: Juneja D, Jain R, Nasa P. Dengue induced acute liver failure: A meta summary of case reports. World J Virol 2024; 13(1): 91457
- URL: https://www.wjgnet.com/2220-3249/full/v13/i1/91457.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i1.91457